substance p has been researched along with ketotifen in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 6 (54.55) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eliakim, R; Karmeli, F; Okon, E; Rachmilewitz, D | 2 |
| Kanai, Y; Misawa, M | 1 |
| Mio, M; Okamoto, M; Tasaka, K | 1 |
| Hachisuka, H; Mori, O; Nomura, H; Okubo, K; Sakamoto, F; Sasai, Y | 1 |
| Kamei, C; Nakamura, S; Tasaka, K | 1 |
| DeMora, F; Ferrer, L; García, G; Puigdemont, A | 1 |
| Aase, S; Gronbech, JE; Lyng, O; Rydning, A | 1 |
| Ando, N; Endoh, T; Honda, T; Kamei, J; Kawamura, K; Nagase, H; Okano, K; Tanaka, T; Togashi, Y; Umeuchi, H; Utsumi, J; Yoshizawa, Y | 1 |
| Honda, T; Nagase, H; Nakao, K; Okano, K; Tanaka, T; Togashi, Y; Umeuchi, H | 1 |
| Hiyama, Y; Ishimura, M; Kataoka, S; Maeda, T; Suda, M | 1 |
11 other study(ies) available for substance p and ketotifen
| Article | Year |
|---|---|
Gastric mucosal damage by ethanol is mediated by substance P and prevented by ketotifen, a mast cell stabilizer.
Topics: Animals; Azepines; Cimetidine; Ethanol; Gastric Acid; Gastric Mucosa; Gastrins; Hydroxyzine; In Vitro Techniques; Ketotifen; Leukotriene B4; Male; Mast Cells; Pepsin A; Peptide Fragments; Platelet Activating Factor; Pyrrolidonecarboxylic Acid; Rats; Rats, Inbred Strains; SRS-A; Substance P; Triazoles | 1991 |
Effect of the new antiallergic drug epinastine on chemical mediator induced bronchoconstrictions in guinea pigs.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Bradykinin; Bronchoconstriction; Dibenzazepines; Guinea Pigs; Histamine; Histamine H1 Antagonists; Imidazoles; Ketotifen; Male; Neurokinin A; Phthalazines; Piperazines; Prostaglandin D2; Prostaglandin Endoperoxides, Synthetic; SRS-A; Substance P | 1991 |
Intracellular calcium release induced by histamine releasers and its inhibition by some antiallergic drugs.
Topics: Aminoquinolines; Animals; Benzhydryl Compounds; Bucladesine; Calcium; Cromolyn Sodium; Histamine Release; Ketotifen; Male; Mast Cells; Membrane Lipids; p-Methoxy-N-methylphenethylamine; Phenothiazines; Rats; Substance P; Terfenadine; Theophylline | 1986 |
Effect of antianaphylactic agents on substance-P induced histamine release from rat peritoneal mast cells.
Topics: Animals; Cromolyn Sodium; Depression, Chemical; Female; Histamine Release; Ketotifen; Male; Mast Cells; ortho-Aminobenzoates; p-Methoxy-N-methylphenethylamine; Peritoneal Cavity; Rats; Rats, Inbred Strains; Substance P | 1988 |
Effects of antiallergic agents including levocabastine on experimental rhinitis in rats.
Topics: Acetylcholine; Animals; Antigens, Helminth; Ascaris; Histamine; Histamine H1 Antagonists; Ketotifen; Male; Nasal Mucosa; Piperidines; Platelet Activating Factor; Rats; Rats, Wistar; Rhinitis; Substance P | 1994 |
Role of vasoactive intestinal peptide (VIP) in pathogenesis of ethanol-induced gastric mucosal damage in rats.
Topics: Acute Disease; Animals; Drug Interactions; Ethanol; Gastric Mucosa; Ketotifen; Leukotrienes; Male; Rats; Stomach Diseases; Substance P; Vasoactive Intestinal Peptide | 1993 |
Effect of H1-antihistamines on histamine release from dispersed canine cutaneous mast cells.
Topics: Animals; Calcimycin; Cell Survival; Cetirizine; Concanavalin A; Dermatitis, Atopic; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Histamine H1 Antagonists; Histamine Release; In Vitro Techniques; Ketotifen; Loratadine; Mast Cells; Skin; Substance P; Terfenadine | 1997 |
Substance P may attenuate gastric hyperemia by a mast cell-dependent mechanism in the damaged gastric mucosa.
Topics: Acids; Animals; Anti-Asthmatic Agents; Aprotinin; Calcitonin Gene-Related Peptide; Cromolyn Sodium; Endopeptidases; Gastric Mucosa; Histamine H1 Antagonists; Hyperemia; Hypertonic Solutions; Ketotifen; Laser-Doppler Flowmetry; Male; Mast Cells; Rats; Rats, Wistar; Serine Proteinase Inhibitors; Sodium Chloride; Stomach; Substance P | 1999 |
Antipruritic activity of the kappa-opioid receptor agonist, TRK-820.
Topics: Animals; Antipruritics; Chlorpheniramine; Disease Models, Animal; Histamine; Histamine H1 Antagonists; Ketotifen; Male; Mice; Mice, Inbred ICR; Morphinans; Motor Activity; Naltrexone; Pruritus; Receptors, Opioid, kappa; Spiro Compounds; Substance P | 2002 |
Involvement of central mu-opioid system in the scratching behavior in mice, and the suppression of it by the activation of kappa-opioid system.
Topics: Animals; Antipruritics; Behavior, Animal; Injections, Intraventricular; Injections, Subcutaneous; Ketotifen; Male; Mice; Morphinans; Morphine; Motor Activity; Naltrexone; Narcotic Antagonists; Pruritus; Receptors, Opioid, kappa; Receptors, Opioid, mu; Spiro Compounds; Substance P | 2003 |
Effects of KP-496, a novel dual antagonist for leukotriene D4 and thromboxane A2 receptors, on contractions induced by various agonists in the guinea pig trachea.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetates; Acetylcholine; Albuterol; Animals; Atropine; Benzoquinones; Carbachol; Chromones; Cyclopropanes; Dinoprost; Drug Evaluation, Preclinical; Guinea Pigs; Heptanoic Acids; Histamine; In Vitro Techniques; Indoles; Indomethacin; Ketanserin; Ketotifen; Leukotriene Antagonists; Leukotriene D4; Male; Muscle Contraction; Muscle, Smooth; Phenylcarbamates; Powders; Procaterol; Prostaglandin Antagonists; Prostaglandin D2; Quinolines; Receptors, Thromboxane A2, Prostaglandin H2; Serotonin; Substance P; Sulfides; Sulfonamides; Tosyl Compounds; Trachea; Tryptophan | 2006 |